Discover
ECOR
electroCore, Inc.
8.30
2 x 6.31
2 x 10.50
bid
ask
-
0.34
3.94%
2 @ 04:00 PM
7.98 -0.32 (3.86%)
| Ytd | 84.86% | |
| 1y | 58.40% |
8.06
day range
8.96
4.16
52 week range
10.49
| Open | 8.49 | Prev Close | 8.64 | Low | 8.06 | High | 8.96 | Mkt Cap | 68.85M |
| Vol | 113.68K | Avg Vol | 106.32K | EPS | -1.77 | P/E | N/A | Forward P/E | -31.85 |
| Beta | 0.56 | Short Ratio | 0.54 | Inst. Own | 16.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 7.72 | 200-d Avg | 6.21 | 1yr Est | 25.47 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | -0.29 | -0.31 | -0.02 | -6.90% |
| 2024-08-07 | 2024-06 | -0.39 | -0.38 | 0.01 | 2.56% |
| 2024-08-07 | 2024-06 | -0.39 | N/A | N/A | N/A |
| 2024-05-08 | 2024-03 | -0.5 | -0.53 | -0.03 | -6.00% |
| 2024-05-08 | 2024-03 | -0.5 | N/A | N/A | N/A |
| 2024-03-13 | 2023-12 | -0.55 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-18 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-03-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-01-22 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-11-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-08-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-05-04 | HC Wainwright & Co. | Upgrade | Buy |
Profile
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-08-01 | CUNEO F. PETER | Director | 5.67K | Stock Award(Grant) |
| 2024-09-02 | ERRICO THOMAS J. | Director | 250.40K | Stock Award(Grant) |
| 2024-09-02 | GANDOLFO JOHN P | Director | 67.29K | Stock Award(Grant) |
| 2024-06-04 | GOLDBERGER DANIEL S | Chief Executive Officer | 249.57K | Purchase |
| 2024-06-04 | GOLDSTEIN JULIE ANN | Director | 77.38K | Stock Award(Grant) |
| 2023-08-01 | MOODY TREVOR J. | Director | 67.59K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | AWM Investment Company, Inc. | 510.09K | 8.94M | 7.78% |
| 2024-09-29 | Vanguard Group Inc | 168.92K | 2.96M | 2.58% |
| 2024-09-29 | Renaissance Technologies, LLC | 72.99K | 1.28M | 1.11% |
| 2024-06-29 | International Assets Investment Management, LLC | 67.82K | 1.19M | 1.03% |
| 2024-09-29 | Geode Capital Management, LLC | 63.49K | 1.11M | 0.97% |
| 2024-09-29 | Wealthspire Advisors, LLC | 47.50K | 832.16K | 0.72% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 102.78K | 1.80M | 1.57% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 57.51K | 1.01M | 0.88% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 28.85K | 505.50K | 0.44% |
| 2024-10-30 | Fidelity Total Market Index Fund | 12.46K | 218.23K | 0.19% |
| 2024-10-30 | iShares Micro Cap ETF | 11.71K | 205.18K | 0.18% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 10.98K | 192.42K | 0.17% |
Split
| Split | Date |
|---|---|
| 1 : 15 | 2023-02-15 |